Bioinformatics and machine learning-driven discovery of candidate tissue diagnostic markers for endometriosis with experimental verification - Scorecard - MDSpire
Advertisement
Bioinformatics and machine learning-driven discovery of candidate tissue diagnostic markers for endometriosis with experimental verification
Clinical Scorecard: Identification of Potential Tissue Diagnostic Biomarkers for Endometriosis through Bioinformatics and Machine Learning Approaches with Experimental Validation
At a Glance
Category
Detail
Condition
Endometriosis
Key Mechanisms
Extracellular matrix remodeling and immune dysregulation
Target Population
Women of reproductive age with endometriosis
Care Setting
Clinical and research settings
Key Highlights
Four genes (COL6A3, BGN, LAMA4, THBS2) identified as candidate tissue diagnostic markers.
High discriminatory power with AUC > 0.80 for the identified genes.
Immune dysregulation characterized by elevated M1 macrophages and plasma cells.
Histopathological validation in a mice model of endometriosis.
Significant upregulation of candidate genes confirmed via qPCR and Western blot.
Guideline-Based Recommendations
Diagnosis
Utilize identified genes as potential biomarkers for endometriosis diagnosis.
Management
Focus on symptom control and disease delay while considering new biomarkers for targeted therapies.
Monitoring & Follow-up
Assess immune cell infiltration and gene expression in endometriosis tissues.
Risks
Consider high recurrence rates and side effects associated with current treatment strategies.
Patient & Prescribing Data
Women diagnosed with endometriosis.
Current treatments focus on symptom management; novel biomarkers may guide future therapies.
Clinical Best Practices
Incorporate bioinformatics approaches for gene identification in endometriosis.
Validate biomarkers through experimental models and clinical data.
